In patients with AH not achieving target AP on monotherapy with irbesartan 150 or amlodipine 5 mg administration of irbesartan/amlodipine combination with possibility of dose titration using 4 fixed combinations was effective in 93.3 % of patients , resulted in significant systolic and diastolic AP lowering in all therapeutic groups , was well tolerated and safe .